Mineralys Therapeutics Inc — Cash Flow (NASDAQ:MLYS) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 81.2 M166.3 M 171.33 M Cash from investing activities 160.47 M114.96 M 369.83 M Cash from financing activities 203.25 M116.14 M 494.39 M Free cash flow 81.2 M166.2 M 171.33 M

ニュース

Rodman sells Mineralys Therapeutics (MLYS) stock for $11,505

Mineralys Therapeutics MLYS officer sells $569k in stock

Rodman sells Mineralys (MLYS) shares for $13,353

Levy, Mineralys Therapeutics CFO, sells $345k in MLYS stock

Mineralys Therapeutics CEO Congleton sells $529k in MLYS stock

Mineralys Therapeutics MLYS officer sells $277k in stock

Mineralys: Pre-NDA Feedback Sets Stage For A Pivotal 2026 (NASDAQ:MLYS)

The Zacks Analyst Blog Mineralys, Lyell, Insmed and Nektar

4 Drug, Biotech Stocks Rising More Than 50% in 2025 With Room to Grow

Mineralys stock price target raised to $52 by Stifel on strong trial data

Mineralys hypertension drug trial featured in JAMA’s top research of 2025

Wall Street Analysts Think Mineralys Therapeutics, Inc. (MLYS) Could Surge 27.55%: Read This Before Placing a Bet